XLK has had a sharp reversal since the last note: the ETF is up 7% on the week to $196.27, yet short interest has continued to climb — creating the kind of squeeze setup that makes broad-market hedges expensive to hold.
The short side is in an awkward spot. Short interest now stands at 7.1% of free float, up another 6.6% on the week and 23% higher than a month ago. That prior note flagged the build as a deliberate institutional hedge into weakness. The stock has since rallied hard, meaning shorts that added through last week are sitting on losses. Yet they haven't covered — the daily share count has ticked up two sessions running. The ORTEX short score has also drifted higher all week, reaching 52.3 on Tuesday from 46.2 just nine sessions ago, reflecting a consistent accumulation pattern rather than a one-day event.
The lending market confirms that pressure is building from both directions. Availability has tightened sharply — down to 130% from above 160% a week ago and well above 240% in mid-August. That's a meaningful compression in the borrow pool as shorts add into a rising tape. Cost to borrow has moved with it, doubling over the past month to 0.78%, though in absolute terms it remains low for an ETF of this size. The 52-week availability low is 40.6%, so there is room to tighten further before the borrow market becomes genuinely stressed — but the direction of travel is unambiguous.
Options positioning adds a layer of nuance. The put/call ratio is running at 1.83, modestly above its 20-day average of 1.76, with a z-score just above 1 — slightly more defensive than the recent norm, but not at an extreme. The 52-week range on the PCR runs from 1.34 to a crisis-level 8.12, so the current reading reflects caution rather than panic. What's notable is that the PCR has held consistently above 1.7 since early September, a sustained put bias that predates last week's rally — suggesting options traders had hedged into the move rather than chasing it after the fact.
The institutional picture is steady without being dramatic. Wells Fargo added 1.2 million shares in Q2, the largest disclosed move among the top holders, while Raymond James built a position. On the other side, UBS Asset Management trimmed nearly a million shares and Managed Account Advisors cut by a similar amount. The net flow among the top 15 is roughly flat, consistent with this ETF's role as a tactical vehicle — bought and sold for positioning rather than held as a core conviction.
The key dynamic to watch is whether the shorts who added through September's dip begin to cover as the ETF pushes toward new highs, or whether the put/call ratio and short score continue their quiet drift upward — signalling that institutional players view the current rally as an opportunity to add more protection rather than reduce it.
See the live data behind this article on ORTEX.
Open XLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
